Home » Topics » BioWorld Science

BioWorld Science
RSS

Immune Design opens phase III study of CMB-305 for synovial sarcoma

June 21, 2018

Atossa completes dosing in phase I study of topical endoxifen

June 21, 2018

New phase II trial studies arimoclomol for Gaucher's disease

June 21, 2018

Aquinnah Pharmaceuticals obtains NINDS grant to develop ALS drugs

June 21, 2018

Loss-of-function mutation in TCF12 gene linked to autosomal dominant Kallmann syndrome

June 21, 2018

GSX2 gene identified as causative of basal ganglia agenesis

June 21, 2018

Moxetumomab pasudotox pivotal trial data in relapsed/refractory hairy cell leukemia reported

June 21, 2018

Phase II dose of BAL-101553 defined in solid tumors trial

June 21, 2018

Missense mutations in GLIS1 gene are linked to malformation syndromes

June 21, 2018

Novel collaborative agreement to develop Nanotaxi-formulated DNA dengue vaccine

June 21, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.